SCHEMBL18954553

SCHEMBL18954553

CCCN1C(=O)C(=O)c2cc(Cl)cc(C)c21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.45
▸ TP53 P04637 3/20 0.45
▸ L3MBTL1 Q9Y468 4/20 0.43
▸ ALDH1A1 P00352 10/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HPGD P15428 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16047437 0.86 ALDH1A1 (0.49) L3MBTL1ALDH1A1CES1
SCHEMBL11147987 0.85 ALDH1A1 (0.47) MAPTTP53L3MBTL1ALDH1A1KMT2A
SCHEMBL18954588 0.81 ALDH1A1 (0.53) MAPTTP53L3MBTL1ALDH1A1KMT2A
SCHEMBL18954457 0.80 MAPT (0.43) MAPTTP53L3MBTL1ALDH1A1KMT2A
SCHEMBL18955059 0.77 ALDH1A1 (0.70) MAPTTP53ALDH1A1KMT2AMEN1
SCHEMBL9095600 0.75 DRD2 (0.57) ALDH1A1
SCHEMBL4597472 0.74 ALDH1A1 (0.50) MAPTTP53L3MBTL1ALDH1A1KMT2A
SCHEMBL16048101 0.73 ALDH3A1 (0.65) ALDH1A1
SCHEMBL18954789 0.73 ALDH1A1 (0.71) MAPTTP53L3MBTL1ALDH1A1KMT2A
SCHEMBL18954534 0.73 ALDH1A1 (0.50) MAPTTP53L3MBTL1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback